CVRx announces Medicare win for Barostim therapy
CVRx announced today that CMS proposed to keep its Barostim implant procedure within a certain payment class.
CVRx announced today that CMS proposed to keep its Barostim implant procedure within a certain payment class.
The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed brain metastases.
Patients will have 24/7 access to personalized speech, language and cognitive therapies.
Embedded AI answers patient billing questions in seconds across phone, text, chat, and email
A new report suggests India should offer tax incentives to hospitals treating international patients and support health-tech startups to become a global medical hub by…
New Delhi, July 16 (IANS) The Indian Institute of Technology (IIT) Madras on Wednesday launched India’s lightest active wheelchair — YD One — weighing just…
As physicians and other clinicians in Generation Z make their way into healthcare, there are numerous ways that they are shifting the culture of medicine,…
Battered by multiple years of high health care costs, employers are planning to shift more of the expense to workers in 2026, a new survey…
One of the world’s biggest genetic databases comprises DNA data donated over the years by more than a million retired military service members. | Researchers…
Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content partnerships to build out its advanced…
Nurse scheduling often is a complex, high-level puzzle that needs to balance the demands of hospital operations and nurses’ personal needs. | In 2022, Ilana…